Extended-release Sodium Oxybate in Children

Recruiting now · Phase 2

Conditions studied: Narcolepsy Type 1 (NT 1)

In brief

The main objectives of this study are to determine the treatment preferences of children with narcolepsy type 1 between Extended-release sodium oxybate and Non-extended-release oxybates (Sodium oxybate or a medication with the combination of Calcium, magnesium, potassium, and sodium oxybates). The study will also assess the safety, convenience, and tolerability of Extended-release sodium oxybate. Additionally, the researchers aim to assess how well Extended-release sodium oxybate works in treating narcolepsy type 1.

Key facts

Study ID
NCT06809803
Run by
Stanford University
People needed
36
Starts
2025-10-27
Expected to finish
2027-07-01
Last updated by the study team
2025-11-06

Who can join

Age: 7 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.